Advent International

What Advent International does

Advent International is a global private equity firm founded in 1984 in Boston by Peter Brooke, managing approximately $94 billion in assets under management as of March 31, 2026. The firm invests across five core verticals — Business & Financial Services, Consumer, Healthcare, Industrial, and Technology — executing buyouts, carve-outs, public-to-privates, growth equity, and minority growth investments in 44+ countries. It operates through 17 offices in 13 countries across five continents with 315+ investment professionals, and is one of the largest and longest-tenured global PE firms, having pioneered the PE industry's first global fund in 1987.

The firm's investment platform centers on a flagship series of Global Private Equity (GPE) funds — including the $25 billion GPE X raised in 2022 and a $26 billion successor nearing close in 2026 — complemented by dedicated vehicles such as Advent Tech (technology-focused, launched 2019) and Advent Global Opportunities (non-control public and private). Internally, Advent has built an AI tool called 'IC Robot,' trained on 13 years of investment committee papers and deal outcomes, used to draft and pressure-test deal proposals across the team and reduce IC paper preparation from hours to minutes. The firm also operates a Portfolio Support Group of Operating Partners that executes value creation plans (M&A, pricing, R&D prioritization, operational improvement) across portfolio companies.

Advent generates revenue through management fees on committed/invested capital across successive fund vintages, plus carried interest on successful exits. Its active and recent portfolio includes marquee names such as INNIO (Nasdaq-listed June 2026 at ~$23B), TK Elevator (sold to Kone in 2026 for €29.4B), InPost (€7.8B consortium take-private with FedEx in 2026), Heidrick & Struggles ($1.3B take-private with Corvex in 2025), Sapiens International, Cohance Lifesciences, Culligan, Mangopay, Röhm, Parfums de Marly, and Zentiva (sold to GTCR in 2026). 2026 deal activity alone spanned defense-tech (Shield AI, Saronic), AI infrastructure (OpenAI DeployCo), India (ABHFL, Svatantra, KreditBee), Japan reentry (Japan Well-being), and consumer (Salt & Stone, Natura minority).

Name

Advent International

Legal name

Advent International, L.P.

Website

https://adventinternational.com

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Advent International is a global private equity firm managing approximately $94 billion in AUM across buyout, growth, and sector-focused funds, investing in business services, consumer, healthcare, industrial, and technology companies across 44+ countries through 17 offices on five continents.

Ownership category

akta.pro rank

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices17 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Private equity fund management fees & carried interest: Advent generates revenue by raising private equity funds from institutional investors (LPs) and charging management fees on assets under management (currently ~$94B) plus performance-based carried interest on successful exits across global buyout, growth, and sector-specific funds.
2. Capital deployment and exit returns: Advent invests fund capital into portfolio companies across buyouts, carve-outs, growth equity, public-to-privates, and minority growth, generating returns through IPOs (e.g., INNIO/Nasdaq 2026), strategic sales (e.g., Salt & Stone), and recapitalizations.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Advent International is a global private equity firm that raises institutional capital and invests via buyouts, carve-outs, public-to-privates, growth equity, and minority growth transactions across five core sectors (business and financial services, consumer, healthcare, industrial, and technology). It partners with management teams, founders, and family-owned businesses to transform companies and generate returns through operational improvement, cross-border expansion, and exit events including IPOs and strategic sales.

Product overview

Advent International's offering is a single integrated private-equity investment platform rather than a technology product portfolio, organised as a flagship fund series plus targeted sub-strategies rather than as modular software. The Advent Global Private Equity (GPE) Funds form the core buyout platform and deploy capital across five core sectors, complemented by the non-control Advent Global Opportunities fund and the technology-focused Advent Tech sub-platform. Internally, the firm operates IC Robot, an AI assistant used by deal teams to draft and pressure-test investment committee papers — the most prominent AI capability of Advent's own operations, and distinct from the consumer or enterprise software products offered by its portfolio companies.

Differentiator

Problem solved

Functional benefit

Brands

• Advent Tech: Advent International's first fund focused exclusively on technology investments, raised in 2019.
• Advent Global Opportunities

Products and services

• Advent Global Private Equity (GPE) Funds
• Advent Global Opportunities
• Advent Tech

Quantifiable outcome

• $1 billion in sales uplift at Culligan from global acquisitions during Advent's ownership
• +5 more outcomes

Named customers9 records

Segments6 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature3 records

Partnerships

24 partnerships are on record, tiered core and flagship.

• Booz Allen HamiltoncoreStrategic or Co-development Partner · 22 June 2026Booz Allen Hamilton agreed to acquire Ultra I&C Mission Solutions from Cobham Ultra Group (an Advent International portfolio company) for $720M. The defense technology business specializes in mission-critical software, encryption, and edge-compute products for the U.S. military.
• Heidrick & Struggles (Board Managers)flagshipOthers · 22 June 2026Following take-private in late 2025, Heidrick & Struggles added Aseem Datar (Corporate VP of AI Platform and Quantum at Microsoft) and Leanne Wood (former CHRO of Vodafone) to its Board of Managers, with Tom Monahan as Vice Chairman and Tom Murray as President.
• CoralogixcoreStrategic or Co-development Partner · 3 June 2026Advent co-led (with CPPIB and Greenfield) Coralogix's $200M Series F at a ~$1.6B post-money valuation; total funding to $550M. Advent is also an existing investor participating in earlier rounds.
• Sapiens International CorporationflagshipStrategic or Co-development Partner · 1 June 2026After Advent's December 2025 take-private of Sapiens, ADIA became a significant minority shareholder in June 2026 to accelerate Sapiens' AI strategy for the insurance sector through its Insurance Agentification programme.
• Iscon Balaji FoodscoreStrategic or Co-development Partner · 19 May 2026Advent invested $150M for a significant minority stake in IBF as part of a $215M Series A round (with 360 ONE). IBF manufactures frozen potato products including french fries, hash browns, and coated fries for global QSR and food-service distributors.
• OpenAIflagshipStrategic or Co-development Partner · 11 May 2026OpenAI launched the OpenAI Deployment Company (DeployCo) with $4B+ in initial investment, with Advent as one of five PE backers (alongside TPG, Brookfield, Bain Capital, and Goanna Capital). OpenAI retains majority ownership and super-voting shares; PE investors contribute $4B over 5 years for a guaranteed 17.5% annual return.
• KoneflagshipStrategic or Co-development Partner · 29 April 2026Finnish elevator maker Kone agreed to acquire TK Elevator from Advent and Cinven in a €29.4B ($34.4B) cash-and-stock deal, creating the world's largest lift manufacturer with €20B+ in combined annual sales and €700M in expected annual synergies.
• Amadeus IT SAcoreStrategic or Co-development Partner · 29 April 2026Amadeus agreed to acquire Idemia Public Security from Advent International for €1.2B ($1.4B) in an all-cash deal to expand biometrics and digital identity capabilities across aviation, border control, and hospitality. Expected to close mid-2027.
• CaldiccoreStrategic or Co-development Partner · 23 April 2026Majority-owned by Advent International; under investigation in Brazil for allegedly supplying methanol to a $10B fuel fraud scheme run by Brazil's PCC crime syndicate. Brazil's fuel regulator has restricted Caldic's methanol sales; potential license revocation.
• Indriya (Aditya Birla Housing Finance)coreStrategic or Co-development Partner · 17 April 2026Advent acquired a 14.29% stake in Aditya Birla Housing Finance via Indriya Ltd for ₹2,750 crore (~₹223.12 per share). Advent's CCI approval was received in April 2026; values ABHFL at ₹19,250 crore.
• EbanxcoreStrategic or Co-development Partner · 16 April 2026Advent and FTV Capital-backed Brazilian cross-border payments unicorn expanding into Thailand, Indonesia, Turkey, Malaysia, and Vietnam. Opened Singapore HQ; planning potential New York IPO within two years.
• GTCRcoreStrategic or Co-development Partner · 12 April 2026GTCR completed the acquisition of Zentiva from Advent, expanding its European generics pharmaceutical platform across 40+ countries and 100M+ patients.
• Saronic TechnologiesflagshipStrategic or Co-development Partner · 1 April 2026Advent is an investor in Saronic's $1.75B Series D at $9.25B valuation, part of Advent's commitment to invest up to $1B in next-generation defense companies. Round led by Kleiner Perkins. Saronic builds autonomous surface vessels for the U.S. Navy.
• Cohance Lifesciences (formerly Suven + Cohance merger)flagshipStrategic or Co-development Partner · 1 April 2026Advent holds majority stake in Cohance Lifesciences (created via merger of Suven Pharma, which Advent acquired 50.1% stake in 2023, with Cohance Lifesciences). Advent appointed Umang Vohra (ex-Cipla) as Chairman and CEO.
• Shield AIflagshipStrategic or Co-development Partner · 26 March 2026Advent led Shield AI's $1.5B Series G at a $12.7B post-money valuation (March 2026), with JPMorganChase's Security and Resiliency Initiative co-leading. Advent's investment supports Shield AI's V-BAT and Hivemind autonomous aircraft programs and the Aechelon Technology acquisition.
• HenkelcoreStrategic or Co-development Partner · 26 March 2026Henkel acquired Olaplex from Advent at approximately $1.4B ($2.06 per share), giving Henkel the #2 position in global professional hair care. Advent took Olaplex public in 2021 at a peak valuation of ~$19B.
• Salt & StonecoreOEM/ Whitelabel/ Licensing Partner · 24 March 2026Advent acquired a majority stake in Salt & Stone, the Los Angeles-based premium body care brand founded in 2017. The brand generated over $165 million in 2025 revenue; deal expected to close in April 2026.
• FedExflagshipStrategic or Co-development Partner · 11 February 2026Consortium partner with Advent on the €7.8B recommended all-cash offer for InPost S.A. at EUR 15.60 per share. Advent and FedEx each hold 37% post-settlement, with A&R (16%) and PPF (10%). Combines FedEx's global logistics network with InPost's 61,000+ automated parcel machines. Transaction expected to close H2 2026.
• Corvex Management LPflagshipStrategic or Co-development Partner · 10 December 2025Co-led consortium with Advent for the $1.3 billion take-private acquisition of Heidrick & Struggles International. The company delisted from Nasdaq and continues under its existing brand and leadership.
• Automic GroupcoreStrategic or Co-development Partner · 3 September 2025Advent's first local acquisition in Australia since opening its Sydney office in 2024 — the cloud-based share-registry and financial services platform. Acquisition completed December 2025; financial terms undisclosed.
• Parfums de Marly / INITIO Parfums PrivéscoreStrategic or Co-development Partner · 22 June 2023Advent partnered with founder Julien Sprecher to acquire a majority stake in the parent group of Parfums de Marly and INITIO for over $700 million. Sprecher remains as Executive Chairman. Advent hired Jefferies and Goldman Sachs to explore a sale in 2026 at ~€2B valuation.
• Jasti family (Suven Pharma founders)coreOthers · 26 December 2022Advent entered an agreement to acquire a significant stake in Suven Pharmaceuticals from the Jasti family, with plans to merge with Cohance Lifesciences to create a leading Indian CDMO/API powerhouse, and an open offer for additional 26% of shares.
• LANXESScoreStrategic or Co-development Partner · 31 May 2022Consortium partner with Advent for the €3.85 billion acquisition of Royal DSM's Engineering Materials business, forming a joint venture focused on bio-based and circular solutions. Completion expected H1 2023.
• CinvenflagshipStrategic or Co-development Partner · 1 July 2020Consortium partner with Advent on the €17.2 billion carve-out of thyssenkrupp's Elevator Technology division in July 2020, the largest European PE buyout since 2007. The two firms jointly owned TK Elevator and sold it to Kone in 2026 for €29.4 billion.

Scale indicators8 records

Recent moves13 records

Expansion highlights6 records

Direct peers

• TPG: Diversified global PE firm with flagship buyout funds plus dedicated Capital and Growth vehicles; directly comparable to Advent's flagship-plus-sub-strategy structure and co-investor alongside Advent in OpenAI's DeployCo joint venture.
• Carlyle Group: US-headquartered global PE firm with sector-specialized buyout funds across consumer, healthcare, industrial, and technology; directly comparable to Advent's five-vertical model, and a recent co-defendant with Advent in the SEBI YES Bank insider-trading matter.
• Bain Capital: Global private investment firm with a flagship corporate PE platform and dedicated sector strategies (tech, healthcare, consumer, industrials); co-invested with Advent in OpenAI DeployCo and is identified as a Tokyo-expanding competitor to Advent in Asia-Pacific coverage.
• Cinven: London-headquartered European PE firm focused on large-cap buyouts in healthcare, business services, consumer, and industrials; closest direct peer to Advent in Europe and recent consortium partner on the €17.2B TK Elevator carve-out and the €29.4B Kone exit.
• CVC Capital Partners: European-headquartered global PE firm with flagship buyout funds across consumer, financial services, healthcare, industrials, and technology; comparable to Advent in scale, sector breadth, and cross-border execution capability.
• Permira: Global PE firm with sector-focused buyout strategies across consumer, financial services, healthcare, industrial tech, and technology; comparable to Advent's vertical-specialist model, particularly in European mid-to-large-cap buyouts.

Broad incumbents

• Blackstone: The world's largest alternative asset manager with ~$1T+ AUM and a flagship corporate PE fund series; directly comparable to Advent as a global mega-buyout investor with cross-sector coverage, large flagship vehicles, and active co-investment in AI and infrastructure themes.
• KKR: Global PE platform with multi-strategy funds across buyouts, growth, infrastructure, and credit; competes with Advent for large take-privates and carve-outs (e.g., listed as scaling Tokyo operations alongside Advent and Bain) and shares the same institutional LP base.
• Warburg Pincus: Global PE firm investing across buyouts, growth equity, and sector strategies with strong Asia-Pacific and emerging-markets reach; comparable to Advent in geographic footprint, sector breadth, and use of both control and minority growth structures.
• Apollo Global Management: Large global alternative asset manager with PE buyout, growth, and credit strategies; comparable to Advent in scale and institutional LP base, with significant overlap in large-cap take-privates and complex carve-outs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/adventintl
• Facebookfacebook.com/AdventInternational
• LinkedInlinkedin.com/company/advent-international

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries15 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A252 records

Investments245 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Advent International